Ozempic Is Appealing, but Not Cost-Effective, for Obesity Ozempic Is Appealing, but Not Cost-Effective, for Obesity
Ozempic may not yet be cost-effective, according to a modeling study that compared the drug with surgery.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 18, 2024 Category: Endocrinology Tags: Gastroenterology Source Type: news
Help T1 Diabetes Patients Maximize the Benefits of Exercise Help T1 Diabetes Patients Maximize the Benefits of Exercise
A few simple precautions can help prevent hypoglycemia.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 17, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Nonprescription Weight Loss Product Use Common Among Adolescents Nonprescription Weight Loss Product Use Common Among Adolescents
Prevalence of nonprescription diet pills use among adolescents rises as social media influences become more aggressive than ever.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 17, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Prostate Risks Similar for Testosterone Therapy and Placebo Prostate Risks Similar for Testosterone Therapy and Placebo
For men with hypogonadism and low prostate cancer risk, TRT didn ' t increase the risk for prostate adverse events, said a new analysis likely to inform decision-making.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 17, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
' Subtle Changes' to the 2024 ADA Standards of Care'Subtle Changes' to the 2024 ADA Standards of Care
Anne Peters, MD, provides an overview of the updates to the ADA Standards of Care in Diabetes.Medscape Diabetes & Endocrinology (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 16, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Commentary Source Type: news
Direct Measurement of T3 Is Likely Vital, Say Researchers Direct Measurement of T3 Is Likely Vital, Say Researchers
" It is important to note that the more typically measured biomarkers for thyroid function (T4 and TSH) are poorly linked to free T3 levels, " said researchers.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 15, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Gestational Diabetes May Double Chronic Kidney Disease Risk Gestational Diabetes May Double Chronic Kidney Disease Risk
Gestational diabetes raises the risk for future chronic kidney disease, a risk heightened by subsequent diabetes or hypertension, found an analysis of Danish registry data.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 15, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Why Do GLP-1 Drugs Stop Working, and What to Do About It? Why Do GLP-1 Drugs Stop Working, and What to Do About It?
Everybody has a set point, and every weight loss intervention eventually leads to a plateau, so it helps to have a variety of tools to support patients.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 12, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Automatic Hybrid Insulin Delivery Systems Help Manage T1D Automatic Hybrid Insulin Delivery Systems Help Manage T1D
A prospective evaluation by 16 diabetes specialists in Spain suggests that advanced hybrid closed-loop systems improve glycemic control in patients with type 1 diabetes.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 12, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
So Far, No Ties Between GLP-1s and Suicidal Thoughts So Far, No Ties Between GLP-1s and Suicidal Thoughts
Preliminary FDA investigation finds no evidence of association between the drug class and suicidal thoughts or actions.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 11, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Strict Glycemic Control for Renal Benefit May Come With Risk Strict Glycemic Control for Renal Benefit May Come With Risk
A new study explores if the kidney failure risk equation can identify patients with type 2 diabetes who would show renal improvement with intensive glycemic management.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 11, 2024 Category: Endocrinology Tags: Nephrology Source Type: news
Weight Loss Drug Windfall Attracts Pharma Companies Weight Loss Drug Windfall Attracts Pharma Companies
Pharmaceutical executives from Amgen to Pfizer are plotting to break into the lucrative obesity market by developing or cutting deals to acquire better drugs that will...Reuters Health Information (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 11, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Vertex Pauses Islet Cell Study After Patient Deaths Vertex Pauses Islet Cell Study After Patient Deaths
The deaths are unrelated to the investigational allogeneic stem cell –derived product VX-880, the company says.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 10, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Combined Icodec + Semaglutide Looks Good vs Insulin Combined Icodec + Semaglutide Looks Good vs Insulin
Fixed-ratio once-weekly insulin icodec plus semaglutide product IcoSema was noninferior to daily glargine + aspart.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 10, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Combined Icodec + Semaglutide Looks Good Compared to Insulin Combined Icodec + Semaglutide Looks Good Compared to Insulin
Fixed-ratio once-weekly insulin icodec plus semaglutide product IcoSema was noninferior to daily glargine + aspart.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 10, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
